Georgia Tech Startup Sets Sights on Transforming Heart Failure Care featuring Cardiosense
CardioTag™: A Breakthrough Wearable for Continuous, Noninvasive Heart Failure Monitoring Using Seismocardiography and Machine Learning
“Despite advances in digital health, continuous monitoring of the heart’s mechanical function has remained difficult outside clinical settings,” said Omer Inan, researcher and entrepreneur at Georgia Tech. “Patients and physicians have long needed a tool that provides deeper, real-time insights into heart performance without invasive procedures. We decided to tackle that problem head-on with a wearable device.”
Inan’s lab got to work using seismocardiography, a technique that measures tiny chest vibrations linked to cardiac activity, to explore new ways of monitoring heart health. Out of that work, a collaboration between Georgia Tech, Northwestern, and University of California San Francisco, came the CardioTag™ device, a lightweight wearable patch that captures multiple signals, including electrocardiography and seismocardiography, to provide a more complete view of how the heart functions in everyday life.
Cardiosense, the Georgia Tech spinout advancing CardioTag, is now preparing pilot deployments and expanded clinical trials. For the Office of Commercialization at Georgia Tech, this is another example of research transitioning from the lab to the market, with the potential to improve lives.
